Guangzhou KangRui Biological Pharmaceutical Technology Company
广州康睿生物医药科技股份有限公司

China

1 December 2019 - 30 November 2020

No articles found. Guangzhou KangRui Biological Pharmaceutical Technology Company did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

Guangzhou KangRui Biological Pharmaceutical Technology Company

Return to institution outputs

Latest supplement

Nature Index 2020 Artificial Intelligence

Artificial intelligence is one of the most rapidly advancing and controversial topics in scientific research. As investments and revenues soar year-on-year and nations vie for leadership in the field, AI research output continues its steep, upward trajectory. But there are significant ethical and technical challenges to overcome.

Access free

Research highlights of partners

Research highlights

Sign up for the free weekly Nature Index newsletter
Sign up